These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 25600328)
1. [Carbapenemase-producing enterobacteriae: epidemiology, strategies to control their spread and issues]. Lepelletier D; Batard E; Berthelot P; Zahar JR; Lucet JC; Fournier S; Jarlier V; Grandbastien B Rev Med Interne; 2015 Jul; 36(7):474-9. PubMed ID: 25600328 [TBL] [Abstract][Full Text] [Related]
2. A call for action: managing the emergence of multidrug-resistant Enterobacteriaceae in the acute care settings. Savard P; Perl TM Curr Opin Infect Dis; 2012 Aug; 25(4):371-7. PubMed ID: 22766646 [TBL] [Abstract][Full Text] [Related]
3. Control strategies for carbapenemase-producing Enterobacteriaceae at different levels of the healthcare system. Asensio Á; Cantero M; Shaw E; Vergara-López S Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():61-6. PubMed ID: 25542054 [TBL] [Abstract][Full Text] [Related]
4. Combating the spread of carbapenemases in Enterobacteriaceae: a battle that infection prevention should not lose. Savard P; Perl TM Clin Microbiol Infect; 2014 Sep; 20(9):854-61. PubMed ID: 24980472 [TBL] [Abstract][Full Text] [Related]
5. Evolution of antimicrobial resistance among Enterobacteriaceae (focus on extended spectrum β-lactamases and carbapenemases). Lynch JP; Clark NM; Zhanel GG Expert Opin Pharmacother; 2013 Feb; 14(2):199-210. PubMed ID: 23321047 [TBL] [Abstract][Full Text] [Related]
6. Carbapenemase-producing Enterobacteriaceae: the end of the antibiotic era? Pascual Á; Pintado V; Rodríguez-Baño J; Miró JM Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():1-3. PubMed ID: 25542045 [TBL] [Abstract][Full Text] [Related]
7. Management of multidrug resistant bacterial endemic. Zahar JR; Lesprit P Med Mal Infect; 2014 Sep; 44(9):405-11. PubMed ID: 25169940 [TBL] [Abstract][Full Text] [Related]
8. [Infectious diseases caused by carbapenemase-producing Enterobacteriaceae--a particular challenge for antibacterial therapy]. Stock I Med Monatsschr Pharm; 2014 May; 37(5):162-72; quiz 173-4. PubMed ID: 24908928 [TBL] [Abstract][Full Text] [Related]
9. Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control. Tängdén T; Giske CG J Intern Med; 2015 May; 277(5):501-12. PubMed ID: 25556628 [TBL] [Abstract][Full Text] [Related]
10. Control of an outbreak due to orthopedic infections caused by Enterobacteriaceae producing IMP-4 or IMP-8 carbapenemases. Pang F; Jia XQ; Wang B; Li YH; Zhao QG Pathol Biol (Paris); 2014 Jun; 62(3):152-5. PubMed ID: 24685523 [TBL] [Abstract][Full Text] [Related]
11. Notes from the Field: Carbapenem-resistant Enterobacteriaceae Producing OXA-48-like Carbapenemases--United States, 2010-2015. Lyman M; Walters M; Lonsway D; Rasheed K; Limbago B; Kallen A MMWR Morb Mortal Wkly Rep; 2015 Dec; 64(47):1315-6. PubMed ID: 26633574 [TBL] [Abstract][Full Text] [Related]
13. Link between carbapenemase-producing Enterobacteria carriage and cross-border exchanges: eight-year surveillance in a large French multihospitals institution. Fournier S; Lepainteur M; Kassis-Chikhani N; Huang M; Brun-Buisson C; Jarlier V; J Travel Med; 2012; 19(5):320-3. PubMed ID: 22943275 [TBL] [Abstract][Full Text] [Related]
14. French recommendations for the prevention of 'emerging extensively drug-resistant bacteria' (eXDR) cross-transmission. Lepelletier D; Berthelot P; Lucet JC; Fournier S; Jarlier V; Grandbastien B; J Hosp Infect; 2015 Jul; 90(3):186-95. PubMed ID: 25986165 [TBL] [Abstract][Full Text] [Related]
15. The challenges of carbapenemase-producing Enterobacteriaceae and infection prevention: protecting patients in the chaos. Savard P; Carroll KC; Wilson LE; Perl TM Infect Control Hosp Epidemiol; 2013 Jul; 34(7):730-9. PubMed ID: 23739078 [No Abstract] [Full Text] [Related]
16. [The threat of the carbapenemase-producing enterobacteriaceae in Spain: positioning report of the SEIMC study groups, GEIH and GEMARA]. Oteo J; Calbo E; Rodríguez-Baño J; Oliver A; Hornero A; Ruiz-Garbajosa P; Horcajada JP; Del Pozo JL; Riera M; Sierra R; Bou G; Salavert M Enferm Infecc Microbiol Clin; 2014 Dec; 32(10):666-70. PubMed ID: 24767691 [TBL] [Abstract][Full Text] [Related]
17. [Epidemiology and clinical implications of carbapenemase-producing bacteria in Switzerland]. Abbas M; Cherkaoui A; Fankhauser C; Schrenzel J; Harbarth S Rev Med Suisse; 2012 Apr; 8(338):882-4, 886-9. PubMed ID: 22611624 [TBL] [Abstract][Full Text] [Related]
18. The threat of carbapenem-resistant Enterobacteriaceae in Lebanon: an update on the regional and local epidemiology. El-Herte RI; Kanj SS; Matar GM; Araj GF J Infect Public Health; 2012 Jun; 5(3):233-43. PubMed ID: 22632597 [TBL] [Abstract][Full Text] [Related]